Prot# 120-20: A Randomized, Placebo-Controlled, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Rituximab in Combination with Methotrexate in Patients with Active Rheumatoid Arthritis Who Have Had an Inadequeate Respo

Project: Research project

Project Details

StatusFinished
Effective start/end date5/6/03 → 9/10/10

Funding

  • IDEC Pharmaceuticals Corporation (120-20)